Optimisation de l'utilisation des techniques de modélisation dans le passage de l'étape pré-clinique à clinique du développement d'un médicament

Optimisation de l'utilisation des techniques de modélisation dans le passage de l'étape pré-clinique à clinique du développement d'un médicament

Show other versions (1)

Thèse numérisée par la Division de la gestion de documents et des archives de l'Université de Montréal

Bibliographic Details
Main Author:	Grenier, Julie
Other Authors:	Ducharme, Murray P.
Language:	en
Published:	2012
Subjects:	Pharmacocinétique Pharmacokinetic Population Physiologique Physiological Cyclosporine Allométrie Allometry Absorption intestinale Intestional absorption P-gp CYP3A
Online Access:	http://hdl.handle.net/1866/6686

Similar Items

Optimisation de l'utilisation des techniques de modélisation dans le passage de l'étape pré-clinique à clinique du développement d'un médicament
by: Grenier, Julie
Published: (2012)

The effect of licorice drink on cytochrome P3A6 and P-glycoprotein gene transcription in rabbits
by: Rawia Al-Balawnih, et al.
Published: (2017-03-01)

Effect of verapamil on the pharmacokinetics of hydroxycamptothecin and its potential mechanism
by: Hua Xing, et al.
Published: (2020-01-01)

The effects of triptolide on the pharmacokinetics of sorafenib in rats and its potential mechanism
by: Xianming Wang, et al.
Published: (2017-01-01)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
by: Wei Liu, et al.
Published: (2019-01-01)

Effects of psoralen on the pharmacokinetics of anastrozole in rats
by: Yuzhu Zhang, et al.
Published: (2018-01-01)

Influence of verapamil on the pharmacokinetics of oridonin in rats
by: Jing Liu, et al.
Published: (2019-01-01)

Corrigendum: Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
by: Alessandro Galgani, et al.
Published: (2020-01-01)

Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
by: Alessandro Galgani, et al.
Published: (2018-12-01)

Drug Transport across Porcine Intestine Using an Ussing Chamber System: Regional Differences and the Effect of P-Glycoprotein and CYP3A4 Activity on Drug Absorption
by: Yvonne E. Arnold, et al.
Published: (2019-03-01)

Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism
by: Haihua Shang, et al.
Published: (2021-01-01)

Pharmacokinetic interaction between peimine and paeoniflorin in rats and its potential mechanism
by: Qiangjun Chen, et al.
Published: (2021-01-01)

Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism
by: Huan Zhang, et al.
Published: (2020-01-01)

Effects of glycyrrhizin on the pharmacokinetics of nobiletin in rats and its potential mechanism
by: Hao Wang, et al.
Published: (2020-01-01)

Modélisation et détermination des paramètres pharmacocinétiques du trans-resvératrol par voie topique chez le lapin et prédiction de la pharmacocinétique chez l'humain
by: Schinas, Anna Maria
Published: (2016)

Lipid Drug Carriers for Cancer Therapeutics: An Insight into Lymphatic Targeting, P-gp, CYP3A4 Modulation and Bioavailability Enhancement
by: Shashank Chaturvedi, et al.
Published: (2020-08-01)

SUMOylation of pregnane X receptor suppresses rifampicin-induced CYP3A4 and P-gp expression and activity in LS174T cells
by: Huasen Tan, et al.
Published: (2016-02-01)

Effects of glycyrrhizin on the pharmacokinetics of paeoniflorin in rats and its potential mechanism
by: Hongjuan Sun, et al.
Published: (2019-01-01)

Effects of glycyrrhizin on the pharmacokinetics of asiatic acid in rats and its potential mechanism
by: Ling Guo, et al.
Published: (2018-01-01)

Determination of cepharanthine in rat plasma by LC–MS/MS and its application to a pharmacokinetic study
by: Yingbin Deng, et al.
Published: (2017-01-01)

Potential metabolic resistance mechanisms to ivermectin in Anopheles gambiae: a synergist bioassay study
by: Patricia Nicolas, et al.
Published: (2021-03-01)

Pharmacogénétique des immunomodulateurs chez les receveurs de greffe rénale
by: Roy, Jean-Nicholas
Published: (2016)

L'utilisation de la dompéridone comme substrat marqueur de l'activité in vitro des CYP3A4 et CYP3A5
by: Michaud, Véronique
Published: (2016)

Pharmacokinetic study on the interaction between pachymic acid and bavachin and its potential mechanism
by: Jie Zhang, et al.
Published: (2021-01-01)

Qualitative and Quantitative Assessment of Cytochromes P450 mRNA in Human : Studies in the Liver, Blood and Gastrointestinal Mucosa
by: Thörn, Mari
Published: (2005)

Drug-herb interactions between Scutellaria baicalensis and pharmaceutical drugs: Insights from experimental studies, mechanistic actions to clinical applications
by: Xian Zhou, et al.
Published: (2021-06-01)

Medicinal plant reported with adverse reactions in Cuba: potential interactions with conventional drugs
by: Ioanna Martínez, et al.
Published: (2015-04-01)

Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation
by: Mihwa Kwon, et al.
Published: (2020-09-01)

Association of CYP3A4 and CYP3A5 polymorphisms with Iranian breast cancer patients
by: Elham Badavi, et al.
Published: (2015-07-01)

Digoxin absorption decreased independently of P-gp activity in rats with irinotecan-induced gastrointestinal damage
by: Toshiaki Tsuchitani, et al.
Published: (2021-07-01)

Étude biophysique du cytochrome P4503A4 humain
by: Plante, Mélanie
Published: (2007)

Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)

Variability in Loss of Multiple Enzyme Activities Due to the Human Genetic Variation P284T Located in the Flexible Hinge Region of NADPH Cytochrome P450 Oxidoreductase
by: Shaheena Parween, et al.
Published: (2019-10-01)

Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents
by: Vamshikrishna eManda, et al.
Published: (2014-08-01)

Influência do EPP-AF® na atividade da glicoproteína P e do citocromo P450 em voluntários sadios usando coquetel de marcadores
by: Cusinato, Diego Alberto Ciscato
Published: (2017)

The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population
by: Merve Arici, et al.
Published: (2017-02-01)

Cyclosporine Neoral: A Local Experience
by: Nampoory Mangalathillam, et al.
Published: (1999-01-01)

Pharmacocinétique et pharmacodynamie des inhibiteurs de la transcriptase inverse chez l’enfant
by: Bouazza, Naïm
Published: (2012)

Stability investigations of cytochrome P450 (CYP) enzymes immediately after death in a pig model support the applicability of postmortem hepatic CYP quantification
by: Kata W. Pedersen, et al.
Published: (2021-10-01)

Relative growth and population dynamics of Macrobrachium iheringi (Decapoda, Palaemonidae)
by: Caio dos Santos Nogueira, et al.
Published: (2019-05-01)

Cannot write session to /tmp/vufind_sessions/sess_2br2sfbi0lja39c733dn4d2h3l